Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 146 No. 2728 (2016)

Heterogeneity in testing practices for infections during pregnancy: national survey across Switzerland

  • Karoline Aebi-Popp
  • Christian Kahlert
  • Andri Rauch
  • Beatrice Mosimann
  • David Baud
  • Nicola Low
  • Daniel Surbek
DOI
https://doi.org/10.4414/smw.2016.14325
Cite this as:
Swiss Med Wkly. 2016;146:w14325
Published
03.07.2016

Summary

QUESTION: Detection and treatment of infections during pregnancy are important for both maternal and child health. The objective of this study was to describe testing practices and adherence to current national guidelines in Switzerland.

METHODS: We invited all registered practicing obstetricians and gynaecologists in Switzerland to complete an anonymous web-based questionnaire about strategies for testing for 14 infections during pregnancy. We conducted a descriptive analysis according to demographic characteristics.

RESULTS: Of 1138 invited clinicians, 537 (47.2%) responded and 520 (45.6%) were eligible as they are currently caring for pregnant women. Nearly all eligible respondents tested all pregnant women for group B streptococcus (98.0%), hepatitis B virus (HBV) (96.5%) and human immunodeficiency virus (HIV) (94.7%), in accordance with national guidelines. Although testing for toxoplasmosis is not recommended, 24.1% of respondents tested all women and 32.9% tested at the request of the patient. Hospital doctors were more likely not to test for toxoplasmosis than doctors working in private practice (odds ratio [OR] 2.52, 95% confidence interval [CI] 1.04–6.13, p = 0.04). Only 80.4% of respondents tested all women for syphilis. There were regional differences in testing for some infections. The proportion of clinicians testing all women for HIV, HBV and syphilis was lower in Eastern Switzerland and the Zurich region (69.4% and 61.2%, respectively) than in other regions (range 77.1–88.1%, p <0.001). Most respondents (74.5%) said they would appreciate national guidelines about testing for infections during pregnancy.

CONCLUSIONS: Testing practices for infections in pregnant women vary widely in Switzerland. More extensive national guidelines could improve consistency of testing practices.

References

  1. Cunnington M, Kortsalioudaki C, Heath P. Genitourinary pathogens and preterm birth. Curr Opin Infect Dis. 2013;26:219–30. doi:10.1097/QCO.0b013e328360dc31.
  2. Liu B, Roberts CL, Clarke M, Jorm L, Hunt J, Ward J. Chlamydia and gonorrhoea infections and the risk of adverse obstetric outcomes: a retrospective cohort study. Sex Transm Infect. 2013;89:672–8. doi:10.1136/sextrans-2013-051118.
  3. Newman L, Kamb M, Hawkes S, Gomez G, Say L, Seuc A, et al. Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Med. 2013;10:e1001396. doi:10.1371/journal.pmed.1001396.
  4. Baud D, Goy G, Jaton K, Osterheld M-C, Blumer S, Borel N, et al. Role of Chlamydia trachomatis in miscarriage. Emerg Infect Dis. 2011;17:1630–5. doi:10.3201/eid1709.100865.
  5. Lamont RF, Sobel JD, Carrington D, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, et al. Varicella-zoster virus (chickenpox) infection in pregnancy. BJOG Int J Obstet Gynaecol. 2011;118:1155–62. doi:10.1111/j.1471-0528.2011.02983.x.
  6. Salemi JL, Whiteman VE, August EM, Chandler K, Mbah AK, Salihu HM. Maternal hepatitis B and hepatitis C infection and neonatal neurological outcomes. J Viral Hepat. 2014;21:e144-153. doi:10.1111/jvh.12250.
  7. Moore DL, MacDonald NE, Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Preventing ophthalmia neonatorum. Can J Infect Dis Med Microbiol J Can Mal Infect Microbiol Médicale AMMI Can. 2015;26:122–5.
  8. Hill MG, Menon S, Smith S, Zhang H, Tong X, Browne PC. Screening for Chlamydia and Gonorrhea Cervicitis and Implications for Pregnancy Outcome. Are We Testing and Treating at the Right Time? J Reprod Med. 2015;60:301–8.
  9. Ville Y, Leruez-Ville M. Managing infections in pregnancy. Curr Opin Infect Dis. 2014;27:251–7. doi:10.1097/QCO.0000000000000066.
  10. Bundesamt für Gesundheit – Hepatitis B http://www.bag.admin.ch/themen/medizin/00682/00684/01077/index.html?lang=de (accessed May 22, 2016).
  11. Expertenbriefe – SGGG 2015. http://www.sggg.ch/fachthemen/expertenbriefe/ (accessed November 17, 2015).
  12. Mueller M, Henle A, Droz S, Kind AB, Rohner S, Baumann M, et al. Intrapartum detection of Group B streptococci colonization by rapid PCR-test on labor ward. Eur J Obstet Gynecol Reprod Biol. 2014;176:137–41. doi:10.1016/j.ejogrb.2014.02.039.
  13. Rausch A-V, Gross A, Droz S, Bodmer T, Surbek DV. Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis. J Perinat Med. 2009;37:124–9. doi:10.1515/JPM.2009.020.
  14. Renner RM, Renner A, Schmid S, Hoesli I, Nars P, Holzgreve W, et al. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis. J Perinat Med. 2006;34:32–8. doi:10.1515/JPM.2006.005.
  15. Empfohlene Impfungen für Frauen vor, während und nach der Schwangerschaft: Eidgenössische Kommission für Impffragen (EKIF), Sektion Impfprogramme und Bekämpfungsmassnahmen. Bern: Bundesamt für Gesundheit (BAG). Internet: http://www.bag.admin.ch/themen/medizin/00682/00685/03212/
  16. Meyer Sauteur PM, Trück J, Bosshard PP, Tomaske M, Morán Cadenas F, Lautenschlager S, et al. Congenital syphilis in Switzerland: gone, forgotten, on the return. Swiss Med Wkly. 2012;141:w13325. doi:10.4414/smw.2011.13325.
  17. Boubaker K, Raeber PA, Vaudaux B, Bucher HC, Garweg JG, Hoesli I, et al. Toxoplasmosis during pregnancy and infancy. A new approach for Switzerland. Swiss Med Wkly. 2008;138:1–8.
  18. Swiss cantons and major regions http://www.bfs.admin.ch/bfs/portal/en/index/regionen/thematische_karten/maps/raumgliederung/institutionelle_gliederungen.NewWindow.parsys.0002.1.Preview.html (accessed May 22, 2016).
  19. Fröhlicher S, Reichen-Fahrni G, Müller M, Surbek D, Droz S, Spellerberg B, et al. Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre. Swiss Med Wkly. 2014;144:w13935. doi:10.4414/smw.2014.13935.
  20. Giannoni E, Berger C, Stocker M, Agyeman P, Posfay-Barbe KM, Heininger U, et al. Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland. Pediatr Infect Dis J. 2016;35:222–4. doi:10.1097/INF.0000000000000974.
  21. World Health Organization. WHO | Investment case for eliminating mother-to-child transmission of syphilis. WHO http://www.who.int/reproductivehealth/publications/rtis/9789241504348/en/ (accessed November 17, 2015).
  22. Increase in Incidence of Congenital Syphilis – United States, 2012–2014 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6444a3.htm (accessed November 17, 2015).
  23. Frischknecht F, Sell W, Trummer I, Brühwiler H. Serological testing for infectious diseases in pregnant women: are the guidelines followed? Swiss Med Wkly. 2011;140:w13138. doi:10.4414/smw.2010.13138.
  24. Team EC for DP and C (ECDC)-HCU-E editorial. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system 2010. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19600 (accessed February 18, 2016).
  25. Redelinghuys MJ, Ehlers MM, Dreyer AW, Kock MM. Normal flora and bacterial vaginosis in pregnancy: an overview. Crit Rev Microbiol. 2015:1–12. doi:10.3109/1040841X.2014.954522.
  26. Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013;1:CD000262. doi:10.1002/14651858.CD000262.pub4.
  27. Sangkomkamhang US, Lumbiganon P, Prasertcharoensuk W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. In: The Cochrane Collaboration, editor. Cochrane Database Syst. Rev., Chichester, UK: John Wiley & Sons, Ltd; 2015.
  28. Surbek DV, Hoesli IM, Holzgreve W. Morphology assessed by transvaginal ultrasonography differs in patients in preterm labor with vs. without bacterial vaginosis. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2000;15:242–5. doi:10.1046/j.1469-0705.2000.00102.x.
  29. Low N, Redmond S, Uusküla A, van Bergen J, Ward H, Andersen B, et al. Low N, Redmond S, Uusküla A, van Bergen J, Ward H, Andersen B, et al. Screening for genital chlamydia infection. Cochrane Database Syst Rev. 2016: CD010866 (In press). In: The Cochrane Collaboration, editor. Cochrane Database Syst. Rev., Chichester, UK: John Wiley & Sons, Ltd; 2013.
  30. Current UK NSC recommendations n.d. http://legacy.screening.nhs.uk/screening-recommendations.php (accessed February 22, 2016).
  31. Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control. 2010;59:1–110.
  32. Kinuthia J, Drake AL, Matemo D, Richardson BA, Zeh C, Osborn L, et al. HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics. AIDS Lond Engl. 2015;29:2025–33. doi:10.1097/QAD.0000000000000793.
  33. Bundesamt für Gesundheit – HIV/STI-Statistiken, Analysen und Trends http://www.bag.admin.ch/hiv_aids/05464/12908/12909/12913/index.html?lang=de (accessed December 23, 2015).
  34. Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect. 2004;80:255–63. doi:10.1136/sti.2004.009415.
  35. Meystre-Agustoni G, Jeannin A, de Heller K, Pécoud A, Bodenmann P, Dubois-Arber F. Talking about sexuality with the physician: are patients receiving what they wish? Swiss Med Wkly. 2011. doi:10.4414/smw.2011.13178.
  36. Cottrell EB, Chou R, Wasson N, Rahman B, Guise J-M. Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013;158:109–13. doi:10.7326/0003-4819-158-2-201301150-00575.
  37. Aebi-Popp K, Duppenhtaler A, Rauch A, De Gottardi A, Kahlert C. Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland. J Virus Eradication. 2016:52–4.
  38. Kanninen TT, Dieterich D, Asciutti S. HCV vertical transmission in pregnancy: New horizons in the era of DAAs. Hepatol Baltim Md 2015. doi:10.1002/hep.28032.
  39. Selvapatt N, Ward T, Bailey H, Bennett H, Thorne C, See L-M, et al. Is antenatal screening for hepatitis C virus cost-effective? A decade’s experience at a London centre. J Hepatol. 2015. doi:10.1016/j.jhep.2015.05.015.
  40. Brown RS, McMahon BJ, Lok ASF, Wong JB, Ahmed AT, Mouchli MA, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatol Baltim Md. 2016;63:319–33. doi:10.1002/hep.28302.

Most read articles by the same author(s)

1 2 3 > >>